Department of Infectious Disease, The 103 Military Hospital, Vietnam Military Medical University.
Department of Genomics and Cytogenetics, Institute of Biomedicine and Pharmacy (IBP), Vietnam Military Medical University, Vietnam.
Acta Trop. 2020 Oct;210:105541. doi: 10.1016/j.actatropica.2020.105541. Epub 2020 May 31.
Scrub typhus, caused by Orientia tsutsugamushi, is a common fever in parts of Southern and Southeast Asia. As delayed diagnosis of scrub typhus leads to inappropriate treatment and high mortality rates, of up to 70%, sensitive and rapid detection of O. tsutsugamushi is required for timely and appropriate treatment. Molecular assays, such as PCR and real-time PCR, have been shown to be more sensitive than conventional immunoassay, however, they are only available in centralized laboratories. In contrast to PCR assays, Recombinase Polymerase Amplification (RPA) is conducted under a constant temperature ranging from 24°C to 45°C. Therefore, this technology is very promising for nucleic acid testing in the field, and in resource-limited areas. An RPA assay for the detection of O. tsutsugamushi based on the target gene encoding for the 47 kDa outer membrane protein has been reported, but the primer and probe sequences of this assay are suboptimal for detection of the majority of recently published sequences of O. tsutsugamushi isolates from Southeast Asia. We have established a real-time RPA assay with primer and probe sequences that are optimized for most Southeast Asia's isolates of O. tsutsugamushi. As a result, the new RPA assay showed better performance than the previous assay in detecting O. tsutsugamushi in clinical samples of scrub typhus cases found in Vietnam. The specificity of RPA assay was also evaluated using genomic DNA from microorganisms commonly encountered in the differential diagnosis of scrub typhus, and blood samples from healthy controls and O. tsutsugamushi negative confirmed cases.
恙虫病由恙虫东方体引起,是南亚和东南亚部分地区常见的发热疾病。由于恙虫病的诊断延迟会导致治疗不当和死亡率高达 70%,因此需要敏感和快速的检测恙虫东方体以进行及时和适当的治疗。聚合酶链反应(PCR)和实时 PCR 等分子检测已被证明比传统免疫检测更敏感,但这些方法仅在集中式实验室中可用。与 PCR 检测相比,重组酶聚合酶扩增(RPA)在 24°C 至 45°C 的恒温下进行。因此,这项技术非常有希望用于现场和资源有限地区的核酸检测。已经报道了一种基于编码 47 kDa 外膜蛋白的靶基因的恙虫病东方体检测的 RPA 检测方法,但该检测方法的引物和探针序列对于检测最近发表的东南亚大多数恙虫病东方体分离株的序列并不理想。我们已经建立了一种实时 RPA 检测方法,其引物和探针序列经过优化,适用于大多数东南亚的恙虫病东方体分离株。结果,新的 RPA 检测方法在检测越南发现的恙虫病临床样本中的恙虫病东方体时表现出比以前的检测方法更好的性能。还使用在恙虫病鉴别诊断中常见的微生物的基因组 DNA 以及来自健康对照者和恙虫病东方体阴性确诊病例的血液样本评估了 RPA 检测的特异性。